Added Available Since Mwt logP Heavy Atoms Tranche Download
2005-11-15 In-Stock 2015-08-07 241.251 -1.7 17 BAAA
Find Decoys

Available 3D Representations

pH range Net
charge
H-bond
donors
H-bond
acceptors
tPSA Ų Rotatable
bonds
Apolar
desolvationkcal/mol
Polar
desolvationkcal/mol
Download
Reference -1 6 7 136 2 -5.59 -43.75
Mid pH (7.4) 0 6 7 136 2 -4.44 -11.71
High pH (8.4) -1 5 7 134 2 -5.59 -43.75

Activities based on ChEMBL 20

Run SEA

SEA Predictions based on ChEMBL 20

Gene Description Target Class P-Value Max Tc
NOS3 Nitric oxide synthase, endothelial enzyme / enzyme-other 0 51

References

This substance is not reported in any publications per ChEMBL.

View All 17 Clinical Trials

Trial ID Title Status Phase Start Date Condition(s) Drug(s)
NCT00432822 Long-Term Tetrahydrobiopterin Treatment in PKU Patients of 0-18 Years - Study on Phenylalanine Tolerance and Safety Terminated Phase 2/Phase 3 Unknown
Phenylalanine Hydroxylase Deficiencies
tetrahydrobiopterin (BH4)
NCT02042196 Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women Recruiting Phase 0 Dec 2013
Menopause
Aging
KUVAN
Placebo
Cetrotide
Climara
Placebo transdermal patch
NCT01965912 Kuvan®'s Effect on the Cognition of Children With Phenylketonuria Recruiting Phase 4 Oct 2013
Phenylketonuria
Kuvan®
NCT01732471 Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Subjects With Phenylketonuria Completed Phase 3 Nov 2012
Phenylketonuria
Kuvan®
NCT01706965 Kuvan in People With Schizophrenia and Schizoaffective Disorder Suspended Phase 1/Phase 2 Oct 2012
Schizophrenia
Schizoaffective Disorder
Kuvan
Multivitamin

Comments for this Resource